Shahraz, Anahita
Lin, Yuchen
Mbroh, Joshua
Winkler, Jonas
Liao, Huan
Lackmann, Marie
Bungartz, Annemarie
Zipfel, Peter F.
Skerka, Christine
Neumann, Harald
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (FOR 2953 NE 507/16-1, SFB1192 project B6)
Kidneeds Iowa funds, USA
Rheinische Friedrich-Wilhelms-Universität Bonn
Article History
Received: 14 April 2021
Accepted: 21 March 2022
First Online: 6 April 2022
Competing interests
: HN and AS are named inventors of the submitted patent related to treatment of neurodegenerative and neuroinflammatory diseases by polysialic acid that is assigned to the University of Bonn and the University Hospital of Cologne (patent family WO2014154537A1). The other authors declare no conflict of interest.